about
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancerFrom bench to bedside: immunotherapy for prostate cancerA New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR EffectCytokines as biomarkers of nanoparticle immunotoxicityTumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.Differential effects of Paclitaxel on dendritic cell function.Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancerVaccines against human carcinomas: strategies to improve antitumor immune responses.Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in miceDual roles for immune metagenes in breast cancer prognosis and therapy prediction.α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response.T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalNatural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentiaCellular Mechanism of Newly Synthesized Indoledione Derivative-induced Immunological Death of Tumor Cell.How can grafted breast cancer models be optimized?A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsEnhancing efficacy of therapeutic vaccinations by combination with other modalities.The immunosuppressive side of PDTThe current and emerging role of immunotherapy in prostate cancerProstvac-VF: a vector-based vaccine targeting PSA in prostate cancer.Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer.Poxviral vectors for cancer immunotherapyImmune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features.The impact of T-cell immunity on ovarian cancer outcomes.Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement.Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression.nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors.Therapeutic cancer vaccines in combination with conventional therapy.Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors.Prostate cancer vaccines: the long road to clinical application.Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors.Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent mannerLow-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.Antitumor activities of extracts and compounds from water decoctions of Taxus cuspidata.Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
P2860
Q24684241-2C6F7DD4-4121-46FC-8690-5605C030DE5FQ26864390-C720295F-4753-46DF-80A5-07CF7C0FA9BDQ27300754-4FE863C7-4AC6-4537-AB18-07AE916BDB24Q28383550-78DCE195-6971-4256-B8E5-33E070155292Q33377058-EB9264B8-3491-4140-B3B3-225DF919698DQ33543346-77B16963-A24A-45C2-8084-4CFCD39F2F60Q33608626-23ABC17C-294C-48E3-B780-68F14D424E03Q33734281-0C55F431-E44C-45C1-8D82-FF6AD8DA2921Q33823499-D8E87EF7-7B24-408C-890F-226F7E5BEB68Q34558758-71590465-D417-4D16-98C2-870FFAD0630EQ35029521-67320BA5-7FF4-4EB9-81FA-2B977435FC33Q35212682-C8688546-36F3-4032-BA64-5B65C58A3D90Q35743162-8512BA79-FAA1-4837-ACE4-A860752D2411Q35745511-93E6CD7B-C228-4F6D-91C3-4F11CC176198Q35760911-E846DA02-1119-4CF8-A474-0042F6E9019EQ35889604-19FD4D51-0B07-4629-881E-355C732322FAQ35975387-19B69194-D534-489F-B05C-98DCA2ED68E5Q36113943-159A9044-D0DE-4CD9-AF7F-73E6A208AB61Q36231512-D2D47C68-56A3-4795-8410-FA85BA2F88E6Q36249922-1F3C2F1C-46E2-44B4-8FD2-ABB73E8A58D2Q36254081-A333EA12-96D9-4F2C-AC5F-42F068ADA3F1Q36326737-85389BD1-B9D2-43A2-A031-47331A3208DCQ36350388-A128CD38-2C9C-48D6-A404-87B23DCA1AB1Q36624237-62A67353-941D-4878-93F0-78DCAF5CB5DDQ36874767-280DBA28-9B79-441C-BC43-EDAB94F12CB5Q36965080-A2BE4549-4364-4FDF-BD5A-18A98806AC38Q37101303-67948706-D814-4CD1-A2E3-C2BF55368614Q37118142-4473232A-C19C-41BC-82DC-E951E19F3F2BQ37193049-7790DB7A-C5A9-4825-84E7-06C3BEF9B1EEQ37234841-F794702D-2594-40F6-8083-736E5BFA377BQ37294314-89114DB3-8CCC-4FCB-ACA3-C8F983ED840DQ37536367-D3DFCDB9-7AFD-40E6-8BB4-D87E769412EBQ37771267-F779CB5D-C8E6-4608-95D0-D6BDFC63550BQ37821374-1DAF0577-D906-4028-9B70-620148F3B36DQ38359237-082538E0-616C-468F-B832-251FAB3ABE02Q39279504-CD02B07E-636B-40EC-BB66-C794B2214C04Q39405279-7103673F-949B-4F1C-B1C8-F7CFBB060CF5Q39589931-CD525615-B710-484A-B6F2-D92ED21BBC20Q39634184-28C52957-96B4-4145-BB29-504A1A110AB6Q39858290-5F559F43-1BA1-44BE-8868-C2B07982307B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The immunological effects of taxanes.
@ast
The immunological effects of taxanes.
@en
The immunological effects of taxanes.
@nl
type
label
The immunological effects of taxanes.
@ast
The immunological effects of taxanes.
@en
The immunological effects of taxanes.
@nl
prefLabel
The immunological effects of taxanes.
@ast
The immunological effects of taxanes.
@en
The immunological effects of taxanes.
@nl
P356
P1476
The immunological effects of taxanes.
@en
P2093
P2888
P304
P356
10.1007/S002620000122
P577
2000-07-01T00:00:00Z
P6179
1045120553